Tune into our next episode of the Foundations of PH series with PH expert Dr. Raymond Benza who walks us through the approach, importance, and treatment implications of risk stratification for patients with pulmonary hypertension.
Host: Kathryn del Valle MD, Mayo Clinic, Rochester, MN
Guest: Raymond Benza MD, Chief of Cardiology at Eastern Virginia Medical School and Academic Chair of Cardiology with Sentara Health
00:00 — Podcast Introduction & Foundations of PH Series
00:15 — Host Introduction and Episode Focus
00:34 — Guest Introduction: Dr. Raymond Benza
00:58 — Career Path and Early Exposure to Pulmonary Hypertension
02:15 — Evolution of PH Care and the Rationale for Risk Stratification
03:57 — Why Risk Stratification Matters for Patients and Treatment Decisions
06:24 — Clinical, Functional, Laboratory, and Imaging Tools for Risk Assessment
09:55 — Validated Risk Scores and Use at Baseline vs Follow-Up
14:58 — Risk Stratification Across PH Groups and Model Limitations
18:39 — Case-Based Discussion: High-Risk PAH Patient Evaluation, Hemodynamics, and Treatment Strategy
The podcast was a brief overview of mechanisms that facilitate lung repair during ARDS to resume normal lung function. These included cells and their secreted products such as, Tregs, Macrophages, and Neutrophils, pro-resolving lipid mediators, and cytokines (IL-10, Tgf-b), along with active processes, such as efferocytosis and changes in immunometabolism. We discussed defining ARDS, factors that contribute to lung resolution, and ended with potential therapeutic options for actively promoting repair along with dampening the inflammatory response.
Moderators:
Filiz T. Korkmaz, PhD, Assistant Professor, University of Iowa
Hong Yong Peh, PhD, Research Assistant Professor, National University of Singapore
Discussants:
Bruce D. Levy, M.D., M.Sc.(Hon.), Hersey Professor of the Theory and Practice of Physic, Harvard Medical School, Executive Vice-Chair, Mass General Brigham, Department of Medicine, Brigham and Women’s Hospital
Kymberly Gowdy, PhD, Associate Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, The Ohio State University
Benjamin Singer, MD, Vice Chair for Research, Department of Medicine, Lawrence Hicks Professor of Pulmonary Medicine, Associate Professor, Medicine (Pulmonary and Critical Care), Biochemistry and Molecular Genetics
00:00 — Introduction & Topic Overview
01:30 — Defining ARDS: Clinical vs Mechanistic Perspectives
05:30 — Resolution vs Recovery vs Repair
08:30 — Pro-Inflammatory Mediators & Neutrophil Biology
13:30 — Pro-Resolving Pathways & Specialized Lipid Mediators
19:55 — Regulatory T Cells, IL-10, and Efferocytosis
22:30 — Macrophage Plasticity and the Limits of the M1/M2 Paradigm
27:30 — Pro-Inflammation and Pro-Resolution Occur in Parallel
33:30 — Aging, Immune Dysfunction, and Impaired Resolution
39:30 — Knowledge Gaps and Future Therapeutic Directions in ARDS
In this episode, we share the wisdom of Dr. Lauren Kearney, a BSHSR member, in her strategies for success in community engaged research and making the most of ATS membership.
00:00 – Podcast Opening & Guest Introduction
00:33 – Dr. Kearney's Award & Early-Career Transition
02:03 – Research Focus: Equity, Community Engagement, Smoking Cessation
04:08 – Mentorship Influence & Diverse Training Experiences
06:06 – Entering Community-Engaged Research: Mentors & Skills
08:01 – Value of ATS Membership: Sponsorship & Access to Leaders
10:01 – Navigating ATS as a Trainee & Becoming Involved
12:07 – Practical Advice for Planning ATS Meeting Engagement
14:14 – Overcoming Nervousness & Preparing an Elevator Pitch
17:10 – Peer Community, Continued Growth, & Closing Remarks
In this episode of the Elevator Pitch, brought to you by the ATS Critical Care Assembly, we talk to Dr. Kevin Buell about his work using machine learning to predict optimal oxygenation targets for critically ill patients.
Host: Divya Shankar, MD, Boston University
Guest: Kevin Buell, MBBS, University of Chicago
00:00 Introduction to the Podcast
00:31 Meet Dr. Kevin Buell
01:37 Dr. Buell's Research Interests
02:08 Elevator Pitch: Oxygen Targets Study
03:08 Study Methodology and Results
05:08 Limitations and Machine Learning
07:08 Model Validation and Application
16:19 Future of Machine Learning in Medicine
17:48 Conclusion and Takeaways
19:13 Closing Remarks
This is the second episode of our Advocacy Series — a collection of podcasts dedicated to exploring key issues in pediatric pulmonology.
In this episode, Robyn Cohen, MD, MPH, and Will Feldman, MD, DPhil, MPH, share their experiences in policy-related advocacy, focusing on inhaler policy, including topics related to Flovent (Fluticasone). They discuss recent developments, challenges, and barriers in inhaler policy, as well as practical tips and strategies for engaging in policy work.
00:00 – Podcast Opening, Hosts, Topic Setup & Guest Introductions
02:40 – Early Experiences, Origins of Inhaler Advocacy & Media Attention
05:00 – Pediatric vs Adult Perspectives, Policy Challenges & Initial Industry/Regulatory Issues
10:00 – Ongoing Aftermath of Inhaler Discontinuations, Community Impact & System Barriers
15:00 – Market Forces, Dry-Powder Alternatives, Patents & Device Innovation Limitations
19:57 - Patent Protection, New Products, and Market Incentives
22:01 - Environmental Concerns, Formularies, and Clinician Constraints
24:03 - Recommended Resources and Understanding Patents/PBMs
26:09 - Advocacy Challenges, Publishing Op-Eds, and Media Engagement
29:04 - Policy Barriers, Authorized Generics, and Institutional Advocacy Support
Additional Resources:
Dr. Feldman’s Testimony regarding pharmaceutical patents before the Senate Judiciary Committee:
https://www.judiciary.senate.gov/committee-activity/hearings/ensuring-affordable-and-accessible-medications-examining-competition-in-the-prescription-drug-market
A version of Dr. Feldman’s written testimony:
https://pubmed.ncbi.nlm.nih.gov/40197405/
Letter in Peds Pulmonology describing the experience of inhaler advocacy:
https://pubmed.ncbi.nlm.nih.gov/40105398/
Cohen RT, Christy Sadreameli S, Coates AC, Nelson BA, O'Sullivan BP; Members of the Advocacy Subcommittee of the American Thoracic Society Pediatrics Assembly and the New England Pediatric Pulmonary Consortium. Ensuring Inhaler Access for Children: A Case Study in Advocacy by Pediatric Pulmonologists. Pediatr Pulmonol. 2025 Mar;60(3):e71055. doi: 10.1002/ppul.71055. PMID: 40105398.
Op-Ed from Drs. Christy Sadreameli and Dr. Robyn Cohen:
https://www.usnews.com/opinion/articles/2024-04-18/asthma-inhaler-chaos-leaves-us-doctors-and-the-children-we-treat-out-of-breath
This episode marks the launch of our Advocacy Series, a collection of podcasts dedicated to exploring key issues in Pediatric Pulmonology. In this episode, Dr. Abby Nerlinger and Dr. Anita Shah discuss how to build an effective advocacy portfolio and provide practical guidance for academic advocacy promotion.
Guest
Dr. Abby Nerlinger, MD MPH
Pediatric Hospitalist
Nemours Children’s Hospital, Wilmington, DE
Guest
Dr. Anita Shah, DO MMS MPH
Pediatric Hospitalist
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Host
Dr. Anne Coates, MD
Pediatric Pulmonologist.
Maine Health, Portland, ME
Host
Dr. S. Christy Sadreameli, MD MHS
Pediatric Pulmonologist
Johns Hopkins University School of Medicine, Baltimore, MD
Host
Dr. Matt Wong, DO MPH
Pediatric Pulmonologist.
Children’s Hospital of Los Angeles, Los Angeles, CA
00:00 — Podcast & Host Introductions
00:22 — Episode Focus: Advocacy Portfolios & Academic Promotion
00:41 — Guest Introductions: Dr. Abby Nirlinger & Dr. Anita Shah
01:29 — Backgrounds, Training & Advocacy Roles of Guests
05:11 — Paths Into Advocacy (Shah & Nirlinger)
09:19 — Integrating Advocacy Into Academic Work
15:06 — Origins & Structure of the Advocacy Portfolio
18:57 — Building Evidence & Community Engagement in Advocacy
21:31 — Aligning Advocacy With Institutions, Funding & Protected Time
30:29 — Advocacy Impact: Health Outcomes, Skills, Burnout & Public Messaging
Nov 21, 2025
Tune into Practical PH’s inaugural episode of the Foundations of PH series with PH expert Dr. Namita Sood who takes us through a systematic approach of accurately diagnosing pulmonary hypertension.
00:00 — Podcast Welcome & Series Overview
01:05 – Guest Introduction & Journey Into PH
03:23 – Patient Case Introduction & Key History
06:20 – Physical Exam Findings & Early Risk Assessment
09:04 – Essential Diagnostic Approach
11:40 – Workup Results & ILD Interpretation
15:01 – Next Steps: ILD Care & Right-Heart Cath
17:01 – Group 3 PH Evaluation & Management
20:08 – Treatment Options & Inhaled Treprostinil
22:46 – Key Takeaways & Closing
Dr. Joanne McKell, MD interviews Dr. Erika Moseson, MD, MA physician and podcaster, about her road to environmental advocacy despite a heavy clinical and administrative workload, a pandemic, and a young family. Dr. Moseson is the creator and host of Air Health, Our Health, a host of the ATS podcast Out of the Blue, and member of the ATS Environmental Health Policy committee.
*Produced by the EOPH Assembly
Host: Joanne McKell, MD, Case Western Reserve University School of Medicine
Guest: Erika Mosesón, MD, MA, Pulmonary Section Chair at Legacy Emanuel Health Medical Center
In this episode, Dr. Joanne McKell, MD sits down with Dr. Mary Rice, MD, MPH Chair of the Environmental, Occupational, and Population Health (EOPH) Assembly of the American Thoracic Society. Dr. Rice shares her journey into environmental health, her goals as Chair, and how her clinical work in pulmonary medicine informs her research on air pollution and climate change.
*Produced by the EOPH Assembly
00:01:20 | Early Influences & Environmental Awareness
00:02:30 | From Consulting to Medicine
00:03:30 | The Path to Pulmonary Medicine
00:04:50 | Joining and Leading Within ATS
00:06:10 | Inside the Role of an Assembly Chair
00:07:50 | Goals for the Year Ahead
00:09:10 | The Power of Framing in Science Communication
00:10:50 | Balancing Clinical Practice and Leadership
00:12:30 | Optimism, Perseverance, and Closing Reflections
Host: Joanne L. McKell, MD, Case Western Reserve University School of Medicine
Guest: Mary B. Rice, MD, MPH, Harvard Medical School, Harvard TH Chan School of Public Health
An in-depth exploration of the evolving understanding of inflammation in COPD, focusing on the differences between type 1/3 and type 2 inflammatory pathways and their clinical relevance. Experts will discuss current gaps in COPD management and the potential of precision medicine to improve outcomes for patients with persistent symptoms or frequent exacerbations. The program will also review recent clinical trial data on type 2 biologics, strategies for identifying appropriate candidates through biomarkers and comorbidities, and key areas for future research, including long-term outcomes, treatment tapering, and therapy optimization.
Host:
• Sara Assaf, MD - Assistant Professor, Division of Pulmonary, Critical Care and Sleep at the University of New Mexico
Guests
• Nick Hanania, MD, MS - Director, Airways Clinical Research Center, Brown Foundation, Professor of Medicine, Baylor College of Medicine
• Stephanie Christenson, MD MAS - Associate Professor, Division of Pulmonary, Critical Care, Allergy, & Sleep, UCSF
• Surya P Bhatt MD, MSPH - Professor of Medicine, Endowed Professor of Airways Disease, University of Alabama at Birmingham
• Klaus Rabe, MD, PhD, FERS - Professor of Pulmonary Medicine, University of Kiel
🔹 00:00:00 | Introduction (0–4 min)
🔹 00:04:04 | Setting the Stage: Why Type 2 Inflammation Matters in COPD
🔹 00:08:07 | The Science Behind COPD and Type 2 Pathways
🔹 00:12:08 | How Inflammation Shapes Disease Progression
🔹 00:16:11 | Current and Emerging Treatments for COPD
🔹 00:24:20 | Biomarkers and Precision Medicine
🔹 00:32:25 | New Frontiers and Ongoing Research
🔹 00:52:41 | Wrapping Up and Key Takeaways
Field walking tests are common outcome measures used in pulmonary rehabilitation to measure an individual's exercise capacity. With a growing number of other outcome measures that also assess exercise capacity, should people still continue to use field walking tests? This podcast aims to highlight why field walking tests should still be used and the common pitfalls when executing these tests.
00:00 – Introduction
02:10 – Why Field Walking Tests Matter
06:25 – The Big Three Tests
12:40 – Choosing the Right Test
13:20 – Limitations of Current Field Tests
13:35 – Emerging Role of Step Tests
15:05 – Three Key Takeaways (Dr. Machado)
16:45 – Closing Remarks
17:30 – Outro
**Produced by the PR Assembly
The intersection of pulmonary and palliative medicine is particularly relevant in the care of patients with interstitial lung disease (ILD). The complex medical, psychological, and physical needs of this population necessitate a collaborative approach, integrating the expertise of both specialties. Approaching care with curiosity rather than judgment fosters interdisciplinary partnership, leading to more comprehensive, patient-centered strategies that enhance outcomes for ILD patients and their caregivers across all dimensions of care.
#PulmonaryPalliativeCare
#AdvancedLungDisease
#InterstitialLungDisease
#Partnerships #Collaboration
#PalliativeMedicine #ATS #AAHPM #WESCOEfoundation #AdvancedIllnessPlanning #GoalsOfCare #TeamBasedCare #WholePersonCare #BeCuriousNotJudgmental
*Produced by the BSHSR Assembly